Alternative to Meds Editorial Team
Medically Reviewed by Dr John Motl MD
Table of Contents:
- Video: Medication Titration & Neurochemistry: SNRIs
- What Is Pristiq?
- Pristiq Withdrawal Symptoms
- Safety Tips, Special Notes on Quitting Pristiq
- Risks and Side Effects Associated with Pristiq/desvenlafaxine
- Make a Plan to Safely Discontinue Pristiq
- Testimonial Pristiq Withdrawal Success
- What Is Pristiq (desvenlafaxine) Used For?
- Pristiq (desvenlafaxine) Alternative Names and Slang
- Common and Severe Pristiq Side Effects
- Additional Severe Pristiq Side Effects
- Strategies to Manage Safety Risks for Pristiq Withdrawal
- Pristiq (desvenlafaxine) Withdrawal FAQs
Pristiq (desvenlafaxine) is FDA-approved antidepressant medication for treating MDD (major depressive disorder). Antidepressants are often prescribed off-label though evidence of their benefits relative to risks is reportedly weak.6,16
Would you rather be naturally well instead of chemically altered?
What Is Pristiq?
Pristiq is a timed-release SNRI antidepressant. The generic version is desvenlafaxine. The drug targets serotonin and norepinephrine receptors in ways that are not completely understood. Researchers report that Pristiq acts aggressively on blocking serotonergic receptors at a 10:1 ratio over norepinephrine receptors.15 Research shows that stopping the drug quickly or all at once does not allow the central nervous system enough time to recalibrate, and can carry certain risks to health.
Pristiq (desvenlafaxine) was initially approved for sale by the FDA in 2007 for the treatment of depressive disorders. The US patent expired around 2017, but Pfizer submitted a new drug application for a future extended-release version of desvenlafaxine, “Prism,” to replace Pristiq — however there is no evidence currently that the application has been approved.20 Pristiq was withdrawn from sale to European markets for undisclosed reasons but generic versions are available in the US.
Pristiq (desvenlafaxine) Withdrawal Symptoms
FDA WARNING: Never abruptly stop taking Pristiq©, as rapid or abrupt cessation is associated with withdrawal symptoms that can be severe, and sometimes life-threatening. Always seek competent medical assistance for Pristiq withdrawal treatment.5,7-14,17
For some, Pristiq withdrawal symptoms even when reducing the dosage slowly may be difficult to tolerate. In these cases, close monitoring by medical caregivers throughout the process is recommended. Some persons may choose closely monitored withdrawal done in an inpatient-style program with strong support and care close at hand.
Pristiq withdrawals can include:
- Suicidality 4,8
- Hyperarousal, anxiety, agitation 10
- Dizziness, vertigo, imbalance, lightheadedness 7-9
- Mania, hypomania 4,12,14
- Psychosis, visual and audio hallucinations 10
- Amnesia 11
- Insomnia, disturbed sleep, vivid dreams, nightmares 7-9
- Seizures 4
- Brain zaps, shivers, jolts, “head shock” sensations* 5
- Weakness, myalgia, headache, chills, and other flu-like symptoms 4,8
- Mood swings, i.e., crying spells, depression, irritability 4-8
- Nausea, vomiting 4,6-10
- Diarrhea, gastrointestinal discomfort, constipation, abdominal pain 10,15
- Paresthesia, burning or prickling sensations on the skin 8
- Movement disorder 11,13
*Brain zaps are known to occur when coming off antidepressants, sometimes even when the withdrawal is done slowly. The phenomenon has been associated with lateral eye movements but remains poorly understood. There is no medical explanation beyond the observation that they occur commonly in antidepressant withdrawal.5
Safety Tips, Special Notes on Quitting Pristiq
Because Pristiq (desvenlafaxine) is a timed-release medication, it may be necessary for the prescribing physician to consider cross-tapering or other strategies to overcome this factor. Clinical expertise is essential for these methods of withdrawal to be done correctly, making the process considerably easier for the patient.
Cross-tapering should only be done in an inpatient setting where close monitoring is possible. In this way, one can avoid any risks that can be associated with incorrect dosages, inappropriate drug interactions, or switching medications too abruptly.
Done well, a correct and exact Pristiq taper supplemented with counseling and other social supports can be surprisingly mild.
Risks and Side Effects Associated with Pristiq
Because of the statistics relating to suicidality which have been well documented during many clinical trials both before and after the drug was first approved, Pristiq is not approved to be prescribed for children, teens, or young adults under the age of 25. However, recent research has found that antidepressant drugs are ALSO associated with increased suicidality in adults, though this is not mentioned on the black box that accompanies all such drugs.4,19
Other risks are associated with Pristiq and other similar SNRI antidepressant drugs. All serotonergic medications should be monitored for rare but potentially lethal reactions such as serotonin syndrome or Stevens-Johnson Syndrome. (See below for more detailed information on these side effects). These potential health hazards are other reasons one might consider a medically monitored Pristiq withdrawal and eventual transition to natural Pristiq alternatives.
A wide range of additional adverse effects have been associated with Pristiq (desvenlafaxine) which you will find listed further down in this article. Not everyone who takes Pristiq suffers extreme adverse reactions. Some will experience years of ongoing suffering, and some people will experience minor reactions or none at all. However, some adverse reactions can be life-threatening and would require the appropriate medical intervention.
Make a Plan to Safely Discontinue Pristiq
Where lingering and troublesome adverse effects outweigh the benefits, a person may want to stop taking Pristiq. But one should try to inform oneself of the best ways of stopping Pristiq. FDA guidelines are confusingly vague and very brief on Pristiq withdrawal. The guideline on the drug insert recommends that one reduce the drug as rapidly as possible, but not so quickly as to cause intolerable withdrawal symptoms.4 It is no wonder that doctors in the main are not well-prepared in helping their patients to come off drugs because unfortunately there is little to no training given in medical school on Pristiq withdrawal help. If you are seeking help with Pristiq withdrawal, seek inpatient care but if this is not possible, try and find a physician who is familiar with the process and who has confidence in their ability to help.
When a person elects to stop taking an SNRI medication, or any medication, it is always wise to seek as much information as possible before beginning the process. We can provide much information on request which may help greatly in planning a safe and relatively comfortable Pristiq withdrawal. We urge you to share the information on this page with your prescriber. More information is given below on how to get off Pristiq with addition information related to Pristiq withdrawal help.
Testimonial
Pristiq Withdrawal
Success
At ATMC I was always supported. The staff was great at providing opportunities for me to work toward stability. What helped me here was always keeping a positive outlook and constant encouragement and reminders to keep faith in myself. ~ Jackie
What Is Pristiq (desvenlafaxine) Used For?
Desvenlafaxine is the generic name for Pristiq, which is FDA approved for the treatment of MDD (major depressive disorder) in adults, aged 25 and older.4
The drug is also prescribed off-label for hot flashes associated with menopause, and for women who experience particularly difficult symptoms relating to the menstrual cycle.
Pristiq is considered to be a “non-hormonal” treatment where an alternative hormone treatment is sought to address vasomotor conditions (relating to the muscles and nerves that regulate dilation and constriction of blood vessels) relating to a woman’s menstrual cycle.
Pristiq (desvenlafaxine) Alternative Names and Slang
Desvenlafaxine is the drug’s generic name. Pristiq is not known to be a popularized street drug but has been found in relatively uncommon pharmaceutical drug diversion cases as with other antidepressants. Sometimes called “poor man’s cocaine,” certain antidepressant prescription drugs are crushed and snorted or injected for a rush similar to other stimulant drugs like cocaine or crack. However, such practices often lead to a trip to the nearest hospital for emergency medical care.
Due to Pristiq’s extended-release structure, it is less subject to abuse than immediate-release antidepressant drugs. Perhaps viewed by some as a deterrent, fillers used in prescription pills may be toxic to the skin when injected, potentially creating very deep abscesses that are prone to infection, especially where neglect and poor hygiene can quickly escalate infection and lead to loss of life if left untreated.
Pristiq is one of many brand names for desvenlafaxine (extended release) including:
- Ellefore©
- Khedezla©
- Defaxin ER©
- Deslafax©
- Dvenjoy XR©
- Zyven OD©
- Ventab©
Common and Severe Pristiq Side Effects
Severe Pristiq side effects can occur as with any SNRI drug. These may require immediate medical intervention for the safety of the patient. It is important to be aware of these while taking an SNRI.
Adverse side effects can be mild to extremely harsh and will affect different people in different ways.
Pristiq side effects may include:
- Suicidality 19
- Mania, hypomania 1,4
- Seizures 4
- Cardiac arrest 1
- Severe muscle tightness 1
- Hyponatremia (abnormally low level of sodium in the blood) 4
- Weight gain 15
- Interstitial lung disease, eosinophilic pneumonia 4
- Increased depression or other worsening symptoms 1,4
- Thoughts of self-harm 1
- Unusual bleeding or bruising 1,4
- Abnormal menstrual cycle 1
- Cholesterol and triglyceride elevation 4
- Elevated blood pressure 18,21
- Glaucoma, mydriasis, eye pain, blurred vision, swelling, or redness around eyes 1,4,17
- Renal impairment, frequent urination, difficulty urinating 1,4
- Teeth grinding 1
- Headache 1,15,17
- Tachycardia (rapid heart rate at rest), increased blood pressure 4,15
- Decreased appetite 17
- Trouble speaking clearly 1
- Chills, shivering, cold sweats 1
- Cognitive impairment, confusion 1
- Swelling 1
- Numbness 1
- Shaking, tremors 1
- Nausea, vomiting 1,15,17
- Headache 1,15,17
- Fatigue, drowsiness 1,17
- Insomnia, abnormal dreams 1,17
- Sexual dysfunction 1,15,17
- Anxiety, agitation, irritability, aggressiveness, restlessness 1
- Hyperhidrosis (excessive sweating) 1,17
- Constipation 15,17
- Xerostomia (dry mouth due to dysfunctional saliva glands) 1
- Cough 15
Additional Severe Pristiq Side Effects
Some of the most severe adverse reactions from Pristiq to be aware of are:
- Serotonin Syndrome
- Stevens-Johnson Syndrome
- Suicidality
- DRESS (rashes, hypersensitivity, allergic reactions)
Serotonin Syndrome: When too much serotonin has been activated in the body this can result in a set of life-threatening symptoms including sudden fever, chills, depressed respiration, coma, unconsciousness, and death.
Stevens-Johnson Syndrome: This is a rare but severe hive-like reaction of the skin caused by certain medications such as Pristiq, which also targets moist tissues of the mouth, eyes, throat, airways, anus, etc. First presents with fever and flu-like symptoms, followed by the skin erupting into blisters that darken and peel away leaving raw painful tissue. Dehydration, sepsis, pneumonia, and multiple organ failure associated with this condition can lead to death.
Increased Suicidality: Pristiq was shown to cause an increased risk of suicide in children, teens, and young adults, especially under the age of 25, and is therefore not approved to be prescribed to this age range. However, trials and statistics also show increased suicidality risk in adult populations.
DRESS (drug induced rashes, hypersensitivity): DRESS stands for Drug Reaction with Eosinophilia and Systemic Symptoms. Eosinophils are a specific type of white blood cell which supports the immune system.”DRESS” means a severe immune system/allergic reaction that affects the skin and other organs in severe and life-threatening ways. Manifestations include fever, painful rash that spreads and blisters, facial edema, fatigue, body aches, and other symptoms. It is a class of reactions of this type (such as Stevens-Johnson, TEN, and others) and these require immediate medical treatment.1,4,19,22,23
Strategies to Manage Risks for Pristiq Withdrawal
Coming off an SNRI must be done precisely and gradually. As mentioned earlier, Pristiq or desvenlafaxine is a time-release medication that requires special consideration in how it is safely reduced in dosage. Work with a trusted medical team or caregiver who can help with either cross-tapering, converting to an equivalent non-timed-release drug, or other risk-management strategy.
Prepare for the discontinuation process. Diet, exercise, resolving nutritional deficiencies, adequate sleep, all play significant role in health and are important supports in medication management.
Above all, don’t try it on your own. Seek help and be patient with yourself. Network with peer groups or close friends who most likely will be more than willing to help you through the process. Consider learning relaxation techniques, therapeutic massage, and other healthful activities. And, give yourself the space and time to work through this sometimes challenging task. You can call us for more information on strategies that may be useful for Pristiq withdrawal success.
Pristiq (desvenlafaxine) Withdrawal FAQs
Below are some of the most common questions regarding Pristiq (desvenlafaxine).
for Pristiq Withdrawal Help
1. NAMI authors, “Desvenlafaxine (Pristiq)” National Alliance on Mental Illness [online publication] December 2018 [cited 2026 June 5]
2. Zhang, G., Gao, Z., Guan, S. et al. “Upregulation of excitatory neurons and downregulation of inhibitory neurons in barrel cortex are associated with loss of whisker inputs.” Mol Brain6,&2 (2013). https://doi.org/10.1186/1756-6606-6-2 [cited 2026 June 5]
3. Guzman F MD “Venlafaxine and Desvenlafaxine: Differences and Similarities” Psychopharmacology Institute, 2019 Jun 27 [cited 2026 June 5]
4. FDA drug label Pristiq (desvenlafaxine) 2008 [cited 2026 June 5]
5. Papp A, Onton JA. Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation. Prim Care Companion CNS Disord. 2018 Dec 20;20(6):18m02311. doi: 10.4088/PCC.18m02311. PMID: 30605268.[cited 2026 June 5]
6. Wong J, Motulsky A, Abrahamowicz M, Eguale T, Buckeridge DL, Tamblyn R. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system. BMJ. 2017;356:j603. Published 2017 Feb 21. doi:10.1136/bmj.j603 [cited 2026 June 5]
7. Rosenbaum JF, Zajecka J. Clinical management of antidepressant discontinuation. J Clin Psychiatry. 1997;58 Suppl 7:37-40. PMID: 9219493. [cited 2026 June 5]
8. Henssler J, Heinz A, Brandt L, Bschor T. Antidepressant Withdrawal and Rebound Phenomena. Dtsch Arztebl Int. 2019;116(20):355-361. doi:10.3238/arztebl.2019.0355 [cited 2026 June 5]
9. Gabriel M, Sharma V. Antidepressant discontinuation syndrome. CMAJ. 2017;189(21):E747. doi:10.1503/cmaj.160991 [cited 2026 June 5]
10. Berber MJ. FINISH: remembering the discontinuation syndrome. Flu-like symptoms, Insomnia, Nausea, Imbalance, Sensory disturbances, and Hyperarousal (anxiety/agitation). J Clin Psychiatry. 1998 May;59(5):255. PMID: 9632038. [cited 2026 June 5]
11. Dilsaver SC, Greden JF. Antidepressant withdrawal phenomena. Biol Psychiatry. 1984 Feb;19(2):237-56. PMID: 6324897.[cited 2026 June 5]
12. Dilsaver SC, Kronfol Z, Sackellares JC, Greden JF. Antidepressant withdrawal syndromes: evidence supporting the cholinergic overdrive hypothesis. J Clin Psychopharmacol. 1983 Jun;3(3):157-64. PMID: 6348107. [cited 2026 June 5]
13. Wolfe RM. Antidepressant withdrawal reactions. Am Fam Physician. 1997 Aug;56(2):455-62. Erratum in: Am Fam Physician 1998 Feb 15;57(4):646. PMID: 9262526. [cited 2026 June 5]
14. Howland RH. Potential adverse effects of discontinuing psychotropic drugs: part 2: antidepressant drugs. J Psychosoc Nurs Ment Health Serv. 2010 Jul;48(7):9-12. doi: 10.3928/02793695-20100527-98. Epub 2010 Jun 22. PMID: 20608581. [cited 2026 June 5]
15. Naseeruddin R, Rosani A, Marwaha R. Desvenlafaxine. [Updated 2021 Mar 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534829/ [cited 2026 June 5]
16. Skanland S, Cieslar Pobuda A, “Off-label uses of drugs for depression.” European Journal of Pharmacology Vol 865, 15 December 2019, 172732 as published in Science Direct [cited 2026 June 5]
17. Liebowitz MR, Tourian KA. Efficacy, safety, and tolerability of Desvenlafaxine 50 mg/d for the treatment of major depressive disorder:a systematic review of clinical trials. Prim Care Companion J Clin Psychiatry. 2010;12(3):PCC.09r00845. doi:10.4088/PCC.09r00845blu [cited 2026 June 5]
18. Thase ME, Fayyad R, Cheng RF, Guico-Pabia CJ, Sporn J, Boucher M, Tourian KA. Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis. Curr Med Res Opin. 2015 Apr;31(4):809-20. doi: 10.1185/03007995.2015.1020365. Epub 2015 Mar 26. PMID: 25758058. [cited 2026 June 5]
19. Hengartner M, Ploderl M, Newer-generation Antidepressants and Suicide Risk …. published in the Journal of Psychotherapy Psychosomatics [published June 4, 2019] [cited 2026 Mar 19]
20. Pristiq US Patents Patent 8269040 Expiry published online (ND) [cited 2026 June 5]
21. Nabeel Aslam, Sobia Memon, Hani Wadei, Shehzad Niazi, P0150
EFFECT OF SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS) ON BLOOD PRESSURE VARIABILITY USING 24 HOURS AMBULATORY BLOOD PRESSURE MONITORING, Nephrology Dialysis Transplantation, Volume 35, Issue Supplement_3, June 2020, gfaa142.P0150 [cited 2026 June 5]22. Calle AM, Aguirre N, Ardila JC, Cardona Villa R. DRESS syndrome: A literature review and treatment algorithm. World Allergy Organ J. 2023 Apr 8;16(3):100673. doi: 10.1016/j.waojou.2022.100673. PMID: 37082745; PMCID: PMC10112187.[cited 2026 June 5]
23. Masuka JT, Mchunu N, Mkhize Z, Thandar Y, Mosam A. Selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor associated cutaneous adverse drug reactions: A systematic review of case reports and case series. Australas J Dermatol. 2022 Feb;63(1):e13-e20. doi: 10.1111/ajd.13780. Epub 2021 Dec 27. PMID: 34958129. [cited 2026 June 5]
Originally Published Sep 13, 2018 by Diane Ridaeus
Dr. John Motl, M.D.
Dr. Motl is currently certified by the American Board of Psychiatry and Neurology in Psychiatry, and Board eligible in Neurology and licensed in the state of Arizona. He holds a Bachelor of Science degree with a major in biology and minors in chemistry and philosophy. He graduated from Creighton University School of Medicine with a Doctor of Medicine. Dr. Motl has studied Medical Acupuncture at the Colorado School of Traditional Chinese Medicine and at U.C.L.A.
Social Profile: LinkedIn
Diane is an avid supporter and researcher of natural mental health strategies. Diane received her medical writing and science communication certification through Stanford University and has published over 3 million words on the topics of holistic health, addiction, recovery, and alternative medicine. She has proudly worked with the Alternative to Meds Center since its inception and is grateful for the opportunity to help the founding members develop this world-class center that has helped so many thousands regain natural mental health.